CBSA President and CEO Is Recognized in Colorado Inno as a Top Tech Hire 2021
By: Colorado BioScience Association Date: 01/06/2022
CBSA President and CEO, Elyse Blazevich, has been recognized in Colorado Inno as a top tech hire. Elyse strategically advances CBSA’s work to build a pro-innovation environment for life sciences in Co...
Learn MoreCBSA Champions Life Sciences in 2021 with End of Year Highlights
By: Colorado BioScience Association Date: 12/28/2021
Colorado’s reputation as a leading location for health innovation continues to accelerate. In 2021, we broke the top 10 in a new ranking of top North American life sciences hubs, climbing to #8. We ac...
Learn MoreWeekly Policy Update: Build Back Better Act Stalled in the Senate
By: Colorado BioScience Association Date: 12/23/2021
Over the weekend Democratic Senator Joe Manchin of West Virginia announced that he would be voting ‘no’ on the Build Back Better Act (BBBA). His concerns with the legislation are primar...
Learn MoreWeekly Policy Update: FDA Commissioner Nominee Confirmation Hearing
By: Colorado BioScience Association Date: 12/17/2021
Last month, President Biden announced Robert Califf, M.D. as his nominee for Commissioner of the Food and Drug Administration (FDA). Dr. Califf’s confirmation hearing was held this week by the Senate...
Learn MoreColorado Life Sciences Companies Raise a Record $2.4 Billion in 2021
By: Colorado BioScience Association Date: 12/14/2021
Major IPOs, Venture Capital Funding, and Government Funding Accelerate Health Innovation DENVER – Colorado’s life sciences ecosystem raised $2.4 billion in 2021, a new record for the fast-growing comm...
Learn MoreEssent Biologics and Amnion Foundation Partner to Provide Germinal-Origin Cells to Further Drug Discovery and Regenerative Medicine Research
By: Colorado BioScience Association Date: 12/14/2021
Distribution Agreement Will Allow Access to Innovative Full-Term Placenta-Derived Cells to Support Ground-Breaking Research Centennial, Colo. — December 14, 2021 — Essent Biologics™, a leading supplie...
Learn MoreWeekly Policy Update: Business Implications from Pending Legislative & Regulatory Activities + CBSA USPTO Roundtable
By: Colorado BioScience Association Date: 12/10/2021
In addition to the ongoing conversations in the Senate related to the House of Representatives’ version of the $1.75 trillion Build Back Better Act (BBBA), the federal government will be seeking stric...
Learn MoreWeekly Policy Update: TRIPS Waiver for COVID-19 Vaccines and Treatments Remains Under Consideration by the World Trade Organization
By: Colorado BioScience Association Date: 12/03/2021
CBSA continues to monitor the international debate on the Trade-Relations Aspects of Intellectual Property Rights (TRIPS) Waiver. Our monitoring of the waiver is due the harmful precedent waving of IP...
Learn MorePathways Bioscience Seeks to Optimize Aging
By: Colorado BioScience Association Date: 11/29/2021
Pathways Bioscience’s technology improves healthspan and overcomes health and wellness problems associated with aging. By use of a dietary supplement with naturally occurring plant-based ingredients,...
Learn MoreWeekly Policy Update: World Antimicrobial Awareness Week + Cures 2.0 & PASTEUR Act
By: Colorado BioScience Association Date: 11/24/2021
World Antimicrobial Awareness Week, hosted by the World Health Organization last week, focused on increasing awareness of global antimicrobial resistance (AMR). and encou...
Learn More